nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A pandemic is no private matter: the COVID-19 vaccine mandate in Austria
|
Druml, Christiane |
|
|
10 |
4 |
p. 322-324 |
artikel |
2 |
Baricitinib for patients with severe COVID-19—time to change the standard of care?
|
Supady, Alexander |
|
|
10 |
4 |
p. 314-315 |
artikel |
3 |
Bringing biological ARDS phenotypes to the bedside with machine-learning-based classifiers
|
Whebell, Stephen |
|
|
10 |
4 |
p. 319-320 |
artikel |
4 |
Cardiorespiratory management of Duchenne muscular dystrophy: emerging therapies, neuromuscular genetics, and new clinical challenges
|
Birnkrant, David J |
|
|
10 |
4 |
p. 403-420 |
artikel |
5 |
Combined medical and surgical therapy for chronic rhinosinusitis with nasal polyposis
|
Lipworth, Brian |
|
|
10 |
4 |
p. e38 |
artikel |
6 |
Combined medical and surgical therapy for chronic rhinosinusitis with nasal polyposis – Authors' reply
|
Lourijsen, Evelijn S |
|
|
10 |
4 |
p. e39 |
artikel |
7 |
Correction to Lancet Respir Med 2022; 10: 327–36
|
|
|
|
10 |
4 |
p. e43 |
artikel |
8 |
COVID-19 vaccination in young children
|
Burki, Talha Khan |
|
|
10 |
4 |
p. e41 |
artikel |
9 |
Effects of SARS-CoV-2 on prenatal lung growth assessed by fetal MRI
|
Stoecklein, Sophia |
|
|
10 |
4 |
p. e36-e37 |
artikel |
10 |
Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial
|
Ely, E Wesley |
|
|
10 |
4 |
p. 327-336 |
artikel |
11 |
Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial
|
Lourijsen, Evelijn S |
|
|
10 |
4 |
p. 337-346 |
artikel |
12 |
Epidemic thunderstorm asthma
|
Venkatesan, Priya |
|
|
10 |
4 |
p. 325-326 |
artikel |
13 |
Feasibility of lung cancer screening in resource-poor areas
|
The Lancet Respiratory Medicine, |
|
|
10 |
4 |
p. 313 |
artikel |
14 |
Long-term clinical outcomes of COVID-19 patients treated with imatinib
|
Duijvelaar, Erik |
|
|
10 |
4 |
p. e34-e35 |
artikel |
15 |
New guidelines for paediatric intensive care unit patients
|
Burki, Talha Khan |
|
|
10 |
4 |
p. e42 |
artikel |
16 |
One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study
|
Li, Ni |
|
|
10 |
4 |
p. 378-391 |
artikel |
17 |
One-off low-dose CT lung cancer screening in China: an appropriate strategy?
|
de Koning, Harry J |
|
|
10 |
4 |
p. 320-322 |
artikel |
18 |
Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study
|
Shi, Ting |
|
|
10 |
4 |
p. 347-354 |
artikel |
19 |
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study
|
Izikson, Ruvim |
|
|
10 |
4 |
p. 392-402 |
artikel |
20 |
SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys
|
Chadeau-Hyam, Marc |
|
|
10 |
4 |
p. 355-366 |
artikel |
21 |
Surgery and uncontrolled chronic rhinosinusitis
|
Hopkins, Claire |
|
|
10 |
4 |
p. 315-317 |
artikel |
22 |
Tracing and vaccinating: how to REACT to COVID-19 pandemic
|
Castagnoli, Riccardo |
|
|
10 |
4 |
p. 317-318 |
artikel |
23 |
US EPA signals renewed regulatory scrutiny of toxic air pollution
|
Furlow, Bryant |
|
|
10 |
4 |
p. e40 |
artikel |
24 |
Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis
|
Maddali, Manoj V |
|
|
10 |
4 |
p. 367-377 |
artikel |